Accelerate Diagnostics, Inc. (AXDX) |
|
3.42 0.23 (7.21%)
|
08-18 07:43 |
|
Open: |
3.19 |
Pre. Close: |
3.19 |
|
High:
|
3.737 |
Low:
|
3.1053 |
|
Volume:
|
1,148,242 |
Market Cap:
|
272(M) |
|
|
|
|
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.74 - 3.76 |
3.76 - 3.77 |
|
Low:
|
3.07 - 3.09 |
3.09 - 3.1 |
|
Close:
|
3.39 - 3.42 |
3.42 - 3.44 |
|
Technical analysis |
as of: 2022-08-17 4:21:38 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 4.36  One year: 5.09 |
| Support: |
Support1: 2.15 Support2: 1.17 |
| Resistance: |
Resistance1: 3.73 Resistance2: 4.36 |
| Pivot: |
2.05 |
| Moving Average: |
MA(5): 2.71 MA(20): 1.88
MA(100): 1.13 MA(250): 3.19  |
| MACD: |
MACD(12,26): 0.4 Signal(9): 0.2 |
| Stochastic oscillator: |
%K(14,3): 89 %D(3): 89.5 |
| RSI: |
RSI(14): 84 |
| 52-week: |
High: 7.19 Low: 0.5 |
| Average Vol(K): |
3-Month: 1,126 (K) 10-Days: 858 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AXDX ] has closed above the upper band by 7.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 292.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 18 Aug 2022
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Sees Significant Increase in Short Interest - Defense World
Tue, 16 Aug 2022
Accelerate Diagnostics GAAP EPS of -$0.23 misses by $0.05, revenue of $3.86M beats by $0.11M (NASDAQ:AXDX) - Seeking Alpha
Mon, 15 Aug 2022
Accelerate Diagnostics Q2 2022 Earnings Preview (NASDAQ:AXDX) - Seeking Alpha
Mon, 15 Aug 2022
Healthcare Stocks Moving Monday: INKT, VRDN, TERN, AXDX, IDYA, GLS, MYMD, APGN - InvestorsObserver
Mon, 15 Aug 2022
Hot Stocks: Li, HALO, AXDX, EMBC - Seeking Alpha
Mon, 15 Aug 2022
BD, Accelerate Diagnostics Announce Global Commercial Collaboration - PR Newswire
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
79 (M) |
| Shares Float |
51 (M) |
|
% Held by Insiders
|
33.2 (%) |
|
% Held by Institutions
|
32.1 (%) |
|
Shares Short
|
5,140 (K) |
|
Shares Short P.Month
|
6,730 (K) |
Stock Financials |
|
EPS
|
-1.06 |
|
EPS Est Next Qtl
|
-0.32 |
|
EPS Est This Year
|
-1.21 |
|
EPS Est Next Year
|
-0.99 |
|
Book Value (p.s.)
|
-0.83 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-551.7 |
|
Return on Assets (ttm)
|
-51.8 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
17.5 |
|
Gross Profit (p.s.)
|
-0.01 |
|
Sales Per Share
|
0.15 |
|
EBITDA (p.s.)
|
-0.82 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-47 (M) |
|
Levered Free Cash Flow
|
-17 (M) |
Stock Valuations |
|
PE Ratio
|
-3.24 |
|
PEG Ratio
|
-0.1 |
|
Price to Book value
|
-4.13 |
|
Price to Sales
|
22.23 |
|
Price to Cash Flow
|
-5.84 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
